| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.29e-07 | 3 | 102 | 3 | GO:0035979 | |
| GeneOntologyMolecularFunction | cysteine-type carboxypeptidase activity | 5.16e-07 | 4 | 102 | 3 | GO:0016807 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.28e-06 | 5 | 102 | 3 | GO:0141003 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.52e-06 | 110 | 102 | 7 | GO:0008238 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 2.60e-06 | 43 | 102 | 5 | GO:0004177 | |
| GeneOntologyMolecularFunction | cysteine-type exopeptidase activity | 1.51e-05 | 10 | 102 | 3 | GO:0070004 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 2.07e-05 | 11 | 102 | 3 | GO:0004301 | |
| GeneOntologyMolecularFunction | serpin family protein binding | 2.58e-05 | 2 | 102 | 2 | GO:0097655 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 3.57e-05 | 13 | 102 | 3 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 3.57e-05 | 13 | 102 | 3 | GO:0016803 | |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 7.73e-05 | 3 | 102 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 1.14e-04 | 49 | 102 | 4 | GO:0004180 | |
| GeneOntologyMolecularFunction | myosin V binding | 1.38e-04 | 20 | 102 | 3 | GO:0031489 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 2.42e-04 | 24 | 102 | 3 | GO:0030742 | |
| GeneOntologyMolecularFunction | kininogen binding | 2.56e-04 | 5 | 102 | 2 | GO:0030984 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 3.09e-04 | 26 | 102 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.77e-04 | 343 | 102 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | histone kinase activity | 3.86e-04 | 28 | 102 | 3 | GO:0035173 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 4.54e-04 | 70 | 102 | 4 | GO:0008235 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.74e-04 | 459 | 102 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 6.32e-04 | 33 | 102 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | myosin binding | 9.46e-04 | 85 | 102 | 4 | GO:0017022 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 1.38e-03 | 94 | 102 | 4 | GO:0050660 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYLK SPTAN1 KIF16B RAB3D NEB PARVG RAB3C KIF3A TTLL2 STARD9 PLEKHH2 USH2A RAB3B NOS2 | 1.38e-03 | 1099 | 102 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | channel activity | 1.47e-03 | 525 | 102 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.49e-03 | 526 | 102 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.63e-03 | 334 | 102 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | peptidase activity | ANPEP NPEPPS CAPNS2 MMP21 CPB1 MINDY2 CNTNAP5 LTA4H CTSL CTSV | 1.89e-03 | 654 | 102 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX60 CFTR KIF16B RAB3D ATP13A5 RAB3C KIF3A GSPT2 ATP11B ABCA5 RAB3B | 2.01e-03 | 775 | 102 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CFTR ATP13A5 PKD1L3 HVCN1 CHRNA2 RYR1 PIEZO2 ATP11B TRPM3 HTR3B CNGA1 | 2.41e-03 | 793 | 102 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.96e-03 | 16 | 102 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | FMN binding | 2.96e-03 | 16 | 102 | 2 | GO:0010181 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.13e-03 | 193 | 102 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 3.34e-03 | 17 | 102 | 2 | GO:0008574 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.42e-03 | 197 | 102 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 3.64e-03 | 200 | 102 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX60 CFTR KIF16B RAB3D ATP13A5 RAB3C KIF3A GSPT2 ATP11B ABCA5 RAB3B | 3.70e-03 | 839 | 102 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX60 CFTR KIF16B RAB3D ATP13A5 RAB3C KIF3A GSPT2 ATP11B ABCA5 RAB3B | 3.74e-03 | 840 | 102 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX60 CFTR KIF16B RAB3D ATP13A5 RAB3C KIF3A GSPT2 ATP11B ABCA5 RAB3B | 3.74e-03 | 840 | 102 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.20e-03 | 614 | 102 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.34e-03 | 129 | 102 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 4.62e-03 | 20 | 102 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.09e-03 | 21 | 102 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.53e-03 | 70 | 102 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 5.79e-03 | 140 | 102 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | calmodulin binding | 6.55e-03 | 230 | 102 | 5 | GO:0005516 | |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 2.33e-05 | 2 | 100 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 2.33e-05 | 2 | 100 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 2.33e-05 | 2 | 100 | 2 | GO:1904882 | |
| GeneOntologyBiologicalProcess | peptidyl-cysteine methylation | 6.96e-05 | 3 | 100 | 2 | GO:0018125 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization to telomere | 6.96e-05 | 3 | 100 | 2 | GO:0097694 | |
| GeneOntologyBiologicalProcess | establishment of protein-containing complex localization to telomere | 6.96e-05 | 3 | 100 | 2 | GO:0097695 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MGAM ATR ANPEP CFTR KIF16B RAB3D ATP13A5 HVCN1 RAB3C DIPK2A ARFGEF3 ATP11B ABCA5 PI4KA SEC16A LRP6 ATM RAB3B SORL1 | 2.16e-05 | 1307 | 104 | 19 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | MGAM ATR ANPEP CFTR KIF16B RAB3D ATP13A5 HVCN1 RAB3C DIPK2A ARFGEF3 ATP11B ABCA5 PI4KA SEC16A LRP6 ATM RAB3B SORL1 | 2.61e-05 | 1325 | 104 | 19 | GO:0012506 |
| GeneOntologyCellularComponent | non-motile cilium | 4.46e-04 | 196 | 104 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 6.56e-04 | 139 | 104 | 5 | GO:0097733 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 6.60e-04 | 293 | 104 | 7 | GO:0030658 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell number | 3.15e-08 | 30 | 90 | 6 | MP:0012771 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell morphology | 3.15e-08 | 30 | 90 | 6 | MP:0010840 | |
| MousePheno | increased central memory CD4-positive, alpha-beta T cell number | 3.82e-07 | 24 | 90 | 5 | MP:0010841 | |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell morphology | 1.35e-06 | 55 | 90 | 6 | MP:0010834 | |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell number | 7.85e-06 | 74 | 90 | 6 | MP:0012769 | |
| MousePheno | increased CD4-positive, alpha-beta memory T cell number | 3.76e-05 | 59 | 90 | 5 | MP:0010835 | |
| MousePheno | periodontal ligament necrosis | 4.10e-05 | 2 | 90 | 2 | MP:0030515 | |
| MousePheno | abnormal lymph node medullary sinus morphology | 4.10e-05 | 2 | 90 | 2 | MP:0011222 | |
| MousePheno | dilated lymph node medullary sinus | 4.10e-05 | 2 | 90 | 2 | MP:0011223 | |
| MousePheno | increased central memory CD8 positive, alpha-beta T cell number | 7.22e-05 | 35 | 90 | 4 | MP:0010847 | |
| MousePheno | abnormal CD8-positive, alpha-beta T cell differentiation | 9.02e-05 | 37 | 90 | 4 | MP:0008080 | |
| MousePheno | pancreas inflammation | 9.85e-05 | 72 | 90 | 5 | MP:0001869 | |
| MousePheno | increased effector memory CD4-positive, alpha-beta T cell number | 1.36e-04 | 41 | 90 | 4 | MP:0010844 | |
| MousePheno | abnormal central memory CD8-positive, alpha-beta T cell number | 1.49e-04 | 42 | 90 | 4 | MP:0012772 | |
| MousePheno | abnormal central memory CD8 positive, alpha-beta T cell morphology | 1.49e-04 | 42 | 90 | 4 | MP:0010846 | |
| MousePheno | increased CD4-positive, alpha-beta T cell number | 1.59e-04 | 241 | 90 | 8 | MP:0008074 | |
| MousePheno | abnormal thymus corticomedullary boundary morphology | 1.64e-04 | 17 | 90 | 3 | MP:0009543 | |
| MousePheno | abnormal effector memory CD4-positive, alpha-beta T cell number | 2.52e-04 | 48 | 90 | 4 | MP:0012770 | |
| MousePheno | abnormal effector memory CD4-positive, alpha-beta T cell morphology | 2.52e-04 | 48 | 90 | 4 | MP:0010843 | |
| MousePheno | abnormal lymph node cortex morphology | 2.95e-04 | 50 | 90 | 4 | MP:0002343 | |
| MousePheno | underdeveloped hair follicles | 3.16e-04 | 21 | 90 | 3 | MP:0000382 | |
| MousePheno | abnormal thymus cortex morphology | 3.44e-04 | 52 | 90 | 4 | MP:0002371 | |
| MousePheno | abnormal hair follicle development | 3.97e-04 | 54 | 90 | 4 | MP:0003704 | |
| MousePheno | folliculitis | 4.05e-04 | 5 | 90 | 2 | MP:0000376 | |
| MousePheno | dental pulp necrosis | 4.05e-04 | 5 | 90 | 2 | MP:0013251 | |
| MousePheno | hair follicle outer root sheath hyperplasia | 4.05e-04 | 5 | 90 | 2 | MP:0010688 | |
| MousePheno | enlarged thymus cortex | 4.05e-04 | 5 | 90 | 2 | MP:0013593 | |
| MousePheno | insulitis | 6.03e-04 | 26 | 90 | 3 | MP:0004031 | |
| MousePheno | thick sperm flagellum | 6.05e-04 | 6 | 90 | 2 | MP:0009241 | |
| MousePheno | abnormal memory T cell number | 6.16e-04 | 162 | 90 | 6 | MP:0008048 | |
| MousePheno | abnormal memory T cell morphology | 6.36e-04 | 163 | 90 | 6 | MP:0010833 | |
| Domain | LRRC37AB_C | 6.68e-07 | 4 | 104 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 6.68e-07 | 4 | 104 | 3 | PF14914 | |
| Domain | LRRC37_N | 6.68e-07 | 4 | 104 | 3 | IPR032754 | |
| Domain | LRRC37 | 6.68e-07 | 4 | 104 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 6.68e-07 | 4 | 104 | 3 | IPR015753 | |
| Domain | PI3/4_kinase_CS | 1.18e-06 | 15 | 104 | 4 | IPR018936 | |
| Domain | - | 1.57e-06 | 16 | 104 | 4 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.57e-06 | 16 | 104 | 4 | SM00146 | |
| Domain | FATC | 1.66e-06 | 5 | 104 | 3 | PF02260 | |
| Domain | PI3_PI4_kinase | 2.61e-06 | 18 | 104 | 4 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 2.61e-06 | 18 | 104 | 4 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.61e-06 | 18 | 104 | 4 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 2.61e-06 | 18 | 104 | 4 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 2.61e-06 | 18 | 104 | 4 | PS50290 | |
| Domain | FAT | 3.31e-06 | 6 | 104 | 3 | PS51189 | |
| Domain | FATC | 3.31e-06 | 6 | 104 | 3 | PS51190 | |
| Domain | FAT | 3.31e-06 | 6 | 104 | 3 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 3.31e-06 | 6 | 104 | 3 | IPR003151 | |
| Domain | FATC_dom | 3.31e-06 | 6 | 104 | 3 | IPR003152 | |
| Domain | PIK_FAT | 3.31e-06 | 6 | 104 | 3 | IPR014009 | |
| Domain | FATC | 3.31e-06 | 6 | 104 | 3 | SM01343 | |
| Domain | Peptidase_M1 | 3.56e-05 | 12 | 104 | 3 | IPR001930 | |
| Domain | Peptidase_M1_N | 4.61e-05 | 13 | 104 | 3 | IPR014782 | |
| Domain | Peptidase_M1 | 4.61e-05 | 13 | 104 | 3 | PF01433 | |
| Domain | Ldl_recept_b | 5.84e-05 | 14 | 104 | 3 | PF00058 | |
| Domain | LDLRB | 5.84e-05 | 14 | 104 | 3 | PS51120 | |
| Domain | LY | 7.27e-05 | 15 | 104 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.27e-05 | 15 | 104 | 3 | IPR000033 | |
| Domain | LH2 | 1.29e-04 | 18 | 104 | 3 | SM00308 | |
| Domain | - | 2.07e-04 | 21 | 104 | 3 | 2.60.60.20 | |
| Domain | PLAT | 2.07e-04 | 21 | 104 | 3 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.07e-04 | 21 | 104 | 3 | IPR001024 | |
| Domain | PLAT | 2.07e-04 | 21 | 104 | 3 | PS50095 | |
| Domain | TUDOR | 4.45e-04 | 27 | 104 | 3 | SM00333 | |
| Domain | FAD_binding_1 | 4.54e-04 | 6 | 104 | 2 | PF00667 | |
| Domain | - | 4.54e-04 | 6 | 104 | 2 | 1.20.990.10 | |
| Domain | FAD-binding_1 | 4.54e-04 | 6 | 104 | 2 | IPR003097 | |
| Domain | NADPH_Cyt_P450_Rdtase_dom3 | 4.54e-04 | 6 | 104 | 2 | IPR023173 | |
| Domain | Tudor | 6.10e-04 | 30 | 104 | 3 | IPR002999 | |
| Domain | Prot_inhib_I29 | 6.33e-04 | 7 | 104 | 2 | IPR013201 | |
| Domain | Inhibitor_I29 | 6.33e-04 | 7 | 104 | 2 | PF08246 | |
| Domain | Inhibitor_I29 | 6.33e-04 | 7 | 104 | 2 | SM00848 | |
| Domain | ERAP1-like_C_dom | 8.41e-04 | 8 | 104 | 2 | IPR024571 | |
| Domain | Flavodoxin/NO_synth | 8.41e-04 | 8 | 104 | 2 | IPR008254 | |
| Domain | Flavdoxin-like | 8.41e-04 | 8 | 104 | 2 | IPR001094 | |
| Domain | ERAP1_C | 8.41e-04 | 8 | 104 | 2 | PF11838 | |
| Domain | FLAVODOXIN_LIKE | 8.41e-04 | 8 | 104 | 2 | PS50902 | |
| Domain | Flavodoxin_1 | 8.41e-04 | 8 | 104 | 2 | PF00258 | |
| Domain | P-loop_NTPase | DDX60 CFTR KIF16B RAB3D RAB3C KIF3A SAMD9L GSPT2 ABCA5 STARD9 YLPM1 ASPM RAB3B | 8.53e-04 | 848 | 104 | 13 | IPR027417 |
| Domain | FN3 | 8.66e-04 | 199 | 104 | 6 | PS50853 | |
| Domain | EF-hand_8 | 8.85e-04 | 34 | 104 | 3 | PF13833 | |
| Domain | FN3_dom | 1.12e-03 | 209 | 104 | 6 | IPR003961 | |
| Domain | LAM_G_DOMAIN | 1.23e-03 | 38 | 104 | 3 | PS50025 | |
| Domain | - | 1.33e-03 | 39 | 104 | 3 | 2.120.10.30 | |
| Domain | Pept_asp_AS | 1.34e-03 | 10 | 104 | 2 | IPR025661 | |
| Domain | - | 1.34e-03 | 10 | 104 | 2 | 3.40.50.360 | |
| Domain | Flavoprotein-like_dom | 1.34e-03 | 10 | 104 | 2 | IPR029039 | |
| Domain | Flavoprot_Pyr_Nucl_cyt_Rdtase | 1.34e-03 | 10 | 104 | 2 | IPR001709 | |
| Domain | LDLR_class-A_CS | 1.43e-03 | 40 | 104 | 3 | IPR023415 | |
| Domain | Laminin_G_2 | 1.43e-03 | 40 | 104 | 3 | PF02210 | |
| Domain | Kinesin_motor_CS | 1.53e-03 | 41 | 104 | 3 | IPR019821 | |
| Domain | Pept_his_AS | 1.63e-03 | 11 | 104 | 2 | IPR025660 | |
| Domain | - | 1.88e-03 | 44 | 104 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 1.88e-03 | 44 | 104 | 3 | PF00225 | |
| Domain | KISc | 1.88e-03 | 44 | 104 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.88e-03 | 44 | 104 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.88e-03 | 44 | 104 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.88e-03 | 44 | 104 | 3 | PS50067 | |
| Domain | LamG | 1.88e-03 | 44 | 104 | 3 | SM00282 | |
| Domain | OxRdtase_FAD/NAD-bd | 1.95e-03 | 12 | 104 | 2 | IPR001433 | |
| Domain | NAD_binding_1 | 1.95e-03 | 12 | 104 | 2 | PF00175 | |
| Domain | Ldl_recept_a | 2.01e-03 | 45 | 104 | 3 | PF00057 | |
| Domain | fn3 | 2.13e-03 | 162 | 104 | 5 | PF00041 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.14e-03 | 46 | 104 | 3 | IPR011042 | |
| Domain | - | 2.14e-03 | 46 | 104 | 3 | 4.10.400.10 | |
| Domain | ZINC_PROTEASE | 2.19e-03 | 98 | 104 | 4 | PS00142 | |
| Domain | Pept_C1 | 2.30e-03 | 13 | 104 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 2.30e-03 | 13 | 104 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 2.30e-03 | 13 | 104 | 2 | PF00112 | |
| Domain | Peptidase_C1A | 2.30e-03 | 13 | 104 | 2 | IPR013128 | |
| Domain | LDLRA_1 | 2.42e-03 | 48 | 104 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.57e-03 | 49 | 104 | 3 | IPR002172 | |
| Domain | LDLa | 2.57e-03 | 49 | 104 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.57e-03 | 49 | 104 | 3 | PS50068 | |
| Domain | ARM-type_fold | 2.88e-03 | 339 | 104 | 7 | IPR016024 | |
| Domain | NTF2-like_dom | 3.08e-03 | 15 | 104 | 2 | IPR032710 | |
| Domain | FN3 | 3.77e-03 | 185 | 104 | 5 | SM00060 | |
| Domain | Ion_trans_dom | 3.79e-03 | 114 | 104 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.79e-03 | 114 | 104 | 4 | PF00520 | |
| Domain | Gal_mutarotase_SF_dom | 3.95e-03 | 17 | 104 | 2 | IPR011013 | |
| Domain | Laminin_G | 4.14e-03 | 58 | 104 | 3 | IPR001791 | |
| Domain | Fd_Rdtase_FAD-bd | 4.94e-03 | 19 | 104 | 2 | IPR017927 | |
| Domain | FAD_FR | 4.94e-03 | 19 | 104 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 4.94e-03 | 19 | 104 | 2 | IPR017938 | |
| Pubmed | Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. | 2.75e-08 | 3 | 106 | 3 | 9766667 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 18451257 | ||
| Pubmed | DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells. | 2.75e-08 | 3 | 106 | 3 | 27733644 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 32742255 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 31601897 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 31164689 | ||
| Pubmed | Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. | 2.75e-08 | 3 | 106 | 3 | 19444312 | |
| Pubmed | Rab3 proteins involved in vesicle biogenesis and priming in embryonic mouse chromaffin cells. | 1.10e-07 | 4 | 106 | 3 | 20716109 | |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 15998665 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 22419166 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 12167638 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 15269275 | ||
| Pubmed | Rab3 superprimes synaptic vesicles for release: implications for short-term synaptic plasticity. | 1.10e-07 | 4 | 106 | 3 | 16436611 | |
| Pubmed | Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. | 2.74e-07 | 5 | 106 | 3 | 19596237 | |
| Pubmed | Tctex-1, a novel interaction partner of Rab3D, is required for osteoclastic bone resorption. | 2.74e-07 | 5 | 106 | 3 | 21262767 | |
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 16540648 | ||
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 11598194 | ||
| Pubmed | ATR acts stage specifically to regulate multiple aspects of mammalian meiotic silencing. | 2.74e-07 | 5 | 106 | 3 | 23824539 | |
| Pubmed | Noc2 is essential in normal regulation of exocytosis in endocrine and exocrine cells. | 2.74e-07 | 5 | 106 | 3 | 15159548 | |
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 29976923 | ||
| Pubmed | The complexity of p53 modulation: emerging patterns from divergent signals. | 5.47e-07 | 6 | 106 | 3 | 9765199 | |
| Pubmed | The RAB3-RIM Pathway Is Essential for the Release of Neuromodulators. | 5.47e-07 | 6 | 106 | 3 | 31679900 | |
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 12192047 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHX1 MAN2A2 ATR ANPEP CALU ERO1A TSPAN3 DIPK2A GTF3C1 MSMO1 LRP4 LRP6 ATM PLOD2 CTSL SORL1 | 7.37e-07 | 1201 | 106 | 16 | 35696571 |
| Pubmed | Telomere protection by TPP1/POT1 requires tethering to TIN2. | 9.55e-07 | 7 | 106 | 3 | 22099311 | |
| Pubmed | Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector. | 9.55e-07 | 7 | 106 | 3 | 35871249 | |
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 17171639 | ||
| Pubmed | Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function. | 9.55e-07 | 7 | 106 | 3 | 33542309 | |
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 10673501 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 15456891 | ||
| Pubmed | Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail. | 1.52e-06 | 8 | 106 | 3 | 22184063 | |
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 20810650 | ||
| Pubmed | MYLK SPTAN1 RAB3D MMP21 NEB RNF17 MINDY2 RAB3C GSPT2 GTF3C1 STARD9 YLPM1 ASPM PRKDC ATM RAB3B ATPAF2 | 1.71e-06 | 1442 | 106 | 17 | 35575683 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ACACA PARVG RYR1 SAMD9L LOXHD1 GTF3C1 TRPM3 DROSHA PI4KA LTA4H PRKDC ATM | 2.64e-06 | 736 | 106 | 12 | 29676528 |
| Pubmed | 3.25e-06 | 10 | 106 | 3 | 23064749 | ||
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 3.25e-06 | 10 | 106 | 3 | 18160036 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 4.46e-06 | 11 | 106 | 3 | 20427287 | |
| Pubmed | Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. | 4.46e-06 | 11 | 106 | 3 | 15758953 | |
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 11551930 | ||
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 11709713 | ||
| Pubmed | UTP6 ACACA NPEPPS SPTAN1 GTF3C1 YLPM1 SEC16A LTA4H PRKDC ATM PCM1 | 5.21e-06 | 653 | 106 | 11 | 22586326 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ARID4B ACACA SYTL2 MLXIP RYR1 ARFGEF3 LOXHD1 L3MBTL1 ATP11B PCM1 | 7.62e-06 | 552 | 106 | 10 | 10737800 |
| Pubmed | Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. | 9.20e-06 | 2 | 106 | 2 | 19285939 | |
| Pubmed | Expression variations of DNA damage response genes ATM and ATR in blood cancer patients. | 9.20e-06 | 2 | 106 | 2 | 37338595 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19801522 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 36735789 | ||
| Pubmed | Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis. | 9.20e-06 | 2 | 106 | 2 | 11231155 | |
| Pubmed | Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury. | 9.20e-06 | 2 | 106 | 2 | 28332696 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28851706 | ||
| Pubmed | Impaired turnover of autophagolysosomes in cathepsin L deficiency. | 9.20e-06 | 2 | 106 | 2 | 20536383 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23832258 | ||
| Pubmed | Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. | 9.20e-06 | 2 | 106 | 2 | 16636100 | |
| Pubmed | Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation. | 9.20e-06 | 2 | 106 | 2 | 31010818 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9739054 | ||
| Pubmed | Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. | 9.20e-06 | 2 | 106 | 2 | 10464290 | |
| Pubmed | Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM. | 9.20e-06 | 2 | 106 | 2 | 27939942 | |
| Pubmed | Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM). | 9.20e-06 | 2 | 106 | 2 | 34151669 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21487018 | ||
| Pubmed | DNA structure-specific priming of ATR activation by DNA-PKcs. | 9.20e-06 | 2 | 106 | 2 | 23897887 | |
| Pubmed | A variant of pulmonary alveolar microlithiasis in nackt mice. | 9.20e-06 | 2 | 106 | 2 | 12014504 | |
| Pubmed | Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome. | 9.20e-06 | 2 | 106 | 2 | 16213462 | |
| Pubmed | Mice that express enzymatically inactive cathepsin L exhibit abnormal spermatogenesis. | 9.20e-06 | 2 | 106 | 2 | 12533435 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27442013 | ||
| Pubmed | Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. | 9.20e-06 | 2 | 106 | 2 | 26057167 | |
| Pubmed | Cathepsin L was involved in vascular aging by mediating phenotypic transformation of vascular cells. | 9.20e-06 | 2 | 106 | 2 | 36206719 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24726882 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 3689328 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17671649 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26061708 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21972973 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16705169 | ||
| Pubmed | Biophysical characterisation of calumenin as a charged F508del-CFTR folding modulator. | 9.20e-06 | 2 | 106 | 2 | 25120007 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 2835398 | ||
| Pubmed | Course of Brugia malayi infection in C57BL/6J NOS2 +/+ and -/- mice. | 9.20e-06 | 2 | 106 | 2 | 11426950 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16079282 | ||
| Pubmed | Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. | 9.20e-06 | 2 | 106 | 2 | 18957203 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20103595 | ||
| Pubmed | Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. | 9.20e-06 | 2 | 106 | 2 | 9545226 | |
| Pubmed | Interplay between ATM and ATR in the regulation of common fragile site stability. | 9.20e-06 | 2 | 106 | 2 | 17934520 | |
| Pubmed | Cathepsin L gene expression and promoter activation in rodent granulosa cells. | 9.20e-06 | 2 | 106 | 2 | 14563703 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25483091 | ||
| Pubmed | ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. | 9.20e-06 | 2 | 106 | 2 | 23592994 | |
| Pubmed | Crosstalk between ERO1α and ryanodine receptor in arsenite-dependent mitochondrial ROS formation. | 9.20e-06 | 2 | 106 | 2 | 35189109 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20877570 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19900452 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19527713 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19782648 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19071136 | ||
| Pubmed | ATM-ROS-iNOS axis regulates nitric oxide mediated cellular senescence. | 9.20e-06 | 2 | 106 | 2 | 27845209 | |
| Pubmed | Thymocyte expression of cathepsin L is essential for NKT cell development. | 9.20e-06 | 2 | 106 | 2 | 12368909 | |
| Pubmed | Cloning and characterization of a mouse cysteine proteinase. | 9.20e-06 | 2 | 106 | 2 | 3533924 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 1482371 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12163394 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20347002 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12065055 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17982083 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15154914 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18371340 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26567218 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17189255 | ||
| Cytoband | 3q24 | 4.99e-05 | 31 | 105 | 3 | 3q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q24 | 1.75e-04 | 47 | 105 | 3 | chr3q24 | |
| GeneFamily | Fibronectin type III domain containing | 3.88e-04 | 160 | 70 | 5 | 555 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 7.49e-04 | 46 | 70 | 3 | 622 | |
| GeneFamily | Low density lipoprotein receptors | 1.12e-03 | 13 | 70 | 2 | 634 | |
| GeneFamily | Cathepsins | 1.50e-03 | 15 | 70 | 2 | 470 | |
| GeneFamily | Aminopeptidases|CD molecules | 1.94e-03 | 17 | 70 | 2 | 104 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 2.04e-03 | 65 | 70 | 3 | 388 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.33e-03 | 181 | 70 | 4 | 694 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 7.98e-06 | 179 | 105 | 7 | M39308 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 9.22e-06 | 183 | 105 | 7 | M2993 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_500 | EPHX1 TMEM182 IL13RA1 MINDY2 SAMD9L PIEZO2 ABCA5 ADGRF5 MERTK PLEKHH2 RAB3B | 1.11e-05 | 438 | 105 | 11 | gudmap_kidney_adult_RenCorpuscGlomer_500 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_1000 | EPHX1 TMEM182 IL13RA1 DDX60 MINDY2 SAMD9L PIEZO2 ABCA5 ADGRF5 MERTK PLEKHH2 PLOD2 RAB3B CTSL ALOX12 | 2.70e-05 | 878 | 105 | 15 | gudmap_kidney_adult_RenCorpuscGlomer_1000 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_200 | 3.06e-05 | 179 | 105 | 7 | gudmap_kidney_adult_Podocyte_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_100 | 6.08e-05 | 84 | 105 | 5 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_100 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_100 | 9.88e-05 | 93 | 105 | 5 | gudmap_kidney_adult_Podocyte_MafB_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | KLHL6 EPHX1 IL13RA1 MYLK ANPEP DDX60 CFTR MINDY2 SAMD9L PIEZO2 PLEKHH2 PLOD2 CTSL | 1.21e-04 | 778 | 105 | 13 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_500 | 1.26e-04 | 20 | 105 | 3 | gudmap_kidney_adult_JuxtaGlom_Ren1_k3_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-08 | 184 | 105 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-08 | 184 | 105 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-08 | 184 | 105 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.15e-06 | 143 | 105 | 6 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 160 | 105 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 160 | 105 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-06 | 162 | 105 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-06 | 164 | 105 | 6 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-06 | 164 | 105 | 6 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-06 | 168 | 105 | 6 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intermediate_macrophages|Liver / Manually curated celltypes from each tissue | 3.25e-06 | 171 | 105 | 6 | 25e0333743affdb662223fb5220b8a61fa02ad9f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-06 | 175 | 105 | 6 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 175 | 105 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 176 | 105 | 6 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 176 | 105 | 6 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 4.96e-06 | 184 | 105 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 187 | 105 | 6 | 6be99f71532b7d679d1287ea1bb08245d9538db7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 187 | 105 | 6 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 187 | 105 | 6 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 5.96e-06 | 190 | 105 | 6 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-06 | 190 | 105 | 6 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.14e-06 | 191 | 105 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.14e-06 | 191 | 105 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-06 | 191 | 105 | 6 | abdd93b2313e635f75a750d051a6a01ddc4e2df9 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 6.14e-06 | 191 | 105 | 6 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-06 | 192 | 105 | 6 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.33e-06 | 192 | 105 | 6 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 195 | 105 | 6 | f7d9adadd37209ce1a38e5d621607b9c9270fed8 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 6.92e-06 | 195 | 105 | 6 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.67e-05 | 148 | 105 | 5 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.33e-05 | 155 | 105 | 5 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.76e-05 | 159 | 105 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 4.23e-05 | 163 | 105 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 164 | 105 | 5 | 83141be8dfed85511ea6afda7c76ff4b6b5ef021 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-05 | 166 | 105 | 5 | afba41e15478053f11815acf568d29187de75492 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-05 | 166 | 105 | 5 | eb9c81fa7573de7aff6670e7dad313f02129809f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-05 | 167 | 105 | 5 | edc5f04584b44f99ff9a62bbe0dab6fc044fb334 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.17e-05 | 170 | 105 | 5 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-05 | 171 | 105 | 5 | effcc4b6d26eafc2ca6fa08b6fee2689eff48f0f | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.31e-05 | 171 | 105 | 5 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-05 | 172 | 105 | 5 | 2651dece87c3e3d2d6370f5274ebae357474b825 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-05 | 173 | 105 | 5 | bba8265a58f8f5659dc7b9da2fe27b15033fce34 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.77e-05 | 174 | 105 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.93e-05 | 175 | 105 | 5 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 175 | 105 | 5 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.93e-05 | 175 | 105 | 5 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 176 | 105 | 5 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-05 | 176 | 105 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.09e-05 | 176 | 105 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.26e-05 | 177 | 105 | 5 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-05 | 179 | 105 | 5 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 6.60e-05 | 179 | 105 | 5 | 4e0cf069bc47328eda753a4edc7e89b8915d52bb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 179 | 105 | 5 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic-Meg|bone_marrow / Manually curated celltypes from each tissue | 6.77e-05 | 180 | 105 | 5 | 44ba37bead1ac39bce4d3eef00961063c50ced0d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-05 | 181 | 105 | 5 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.95e-05 | 181 | 105 | 5 | c7a220891567c7539ad5a9ac9db375f0de08ea00 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 181 | 105 | 5 | 75340f0c06977c88f9d2e56265f4aa84d706d2c6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.14e-05 | 182 | 105 | 5 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-05 | 183 | 105 | 5 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.32e-05 | 183 | 105 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | 7.51e-05 | 184 | 105 | 5 | 10607d7d92edcbb92d992900086b90b307421cc3 | |
| ToppCell | RSV-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 7.51e-05 | 184 | 105 | 5 | 1e282d619ef8035437fabe0fd2aefda1c142f7f6 | |
| ToppCell | RSV-Healthy-5|RSV / Virus stimulation, Condition and Cluster | 7.51e-05 | 184 | 105 | 5 | ba958f731de6c9eff60103d483e020e2c0c7af7c | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.71e-05 | 185 | 105 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 7.71e-05 | 185 | 105 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-05 | 185 | 105 | 5 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.91e-05 | 186 | 105 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.91e-05 | 186 | 105 | 5 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 8.11e-05 | 187 | 105 | 5 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.11e-05 | 187 | 105 | 5 | 2a7226adb4d15b92936603bdf05421c50b21f003 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-05 | 188 | 105 | 5 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 8.32e-05 | 188 | 105 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.74e-05 | 190 | 105 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.96e-05 | 191 | 105 | 5 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 8.96e-05 | 191 | 105 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 191 | 105 | 5 | feec8617678b778475747ad406c80231e07fd6f7 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.96e-05 | 191 | 105 | 5 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.96e-05 | 191 | 105 | 5 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.18e-05 | 192 | 105 | 5 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 9.18e-05 | 192 | 105 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 192 | 105 | 5 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 9.18e-05 | 192 | 105 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.18e-05 | 192 | 105 | 5 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 9.18e-05 | 192 | 105 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 9.41e-05 | 193 | 105 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.41e-05 | 193 | 105 | 5 | 93ba635ed69fec9286fe7636b9d258f3d93a22c3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.41e-05 | 193 | 105 | 5 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.41e-05 | 193 | 105 | 5 | 6dfdeb793cb5ad6412b6f808b5687a4e74b6ec65 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 194 | 105 | 5 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 194 | 105 | 5 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.64e-05 | 194 | 105 | 5 | e455cb469157c044126f9b0b308957d4ee1e608b | |
| ToppCell | severe-Myeloid-Neutrophils_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.64e-05 | 194 | 105 | 5 | 1f8edab1c8ba48bc0114429ea47aab378b5830b7 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.64e-05 | 194 | 105 | 5 | e0cfd18a7ea2251163d61312b9397f8a518c8c51 | |
| ToppCell | 356C-Epithelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.87e-05 | 195 | 105 | 5 | d913d0a6c4797d9a873ddea6f340c3f152da1cf3 | |
| ToppCell | (7)_Epithelial-A_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.87e-05 | 195 | 105 | 5 | c9a6c65ee18d83bf34a4713d306a6e30db1325c2 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 9.87e-05 | 195 | 105 | 5 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM3|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.01e-04 | 196 | 105 | 5 | 9faad17aa0b6af5a8ec2dadf7d70b9209d658072 | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.01e-04 | 196 | 105 | 5 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 196 | 105 | 5 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| Drug | polyethylenimine | 2.17e-06 | 128 | 105 | 7 | CID000009033 | |
| Drug | clotrimazole | 4.53e-06 | 143 | 105 | 7 | CID000002812 | |
| Drug | TEMPOL-H | 1.12e-05 | 10 | 105 | 3 | ctd:C505333 | |
| Drug | aristolochic acid | 1.35e-05 | 66 | 105 | 5 | CID000002236 | |
| Drug | mg 8 | 1.53e-05 | 11 | 105 | 3 | CID000069414 | |
| Drug | 4-amino-1,8-naphthalimide | 1.53e-05 | 11 | 105 | 3 | ctd:C086538 | |
| Drug | Serotonin | 1.72e-05 | 117 | 105 | 6 | ctd:D012701 | |
| Drug | ONO-RS-082 | 1.81e-05 | 70 | 105 | 5 | CID006438389 | |
| Drug | sodium linoleate | 2.97e-05 | 342 | 105 | 9 | CID000003931 | |
| Drug | cupric chloride | ANPEP SPTAN1 KIF3A TRPM3 LRP4 LRP6 LTA4H ATM USH2A NOS2 ALOX12 PCM1 | 3.05e-05 | 623 | 105 | 12 | ctd:C029892 |
| Drug | 1,10-phenanthroline | 3.37e-05 | 267 | 105 | 8 | CID000001318 | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 3614_UP | |
| Drug | AC1L1FO5 | 4.17e-05 | 15 | 105 | 3 | CID000003322 | |
| Drug | 8(S),15(S)-diHETE | 4.17e-05 | 15 | 105 | 3 | CID000001897 | |
| Drug | phosphoramide mustard | 4.59e-05 | 43 | 105 | 4 | ctd:C030090 | |
| Drug | Aphidicolin | 6.18e-05 | 17 | 105 | 3 | ctd:D016590 | |
| Drug | Vasopressins | 6.30e-05 | 3 | 105 | 2 | ctd:D014667 | |
| Drug | calcium carbonate phosphate | 6.30e-05 | 3 | 105 | 2 | CID006337635 | |
| Drug | r142 | 6.30e-05 | 3 | 105 | 2 | CID002734672 | |
| Drug | N,N'-diethylethylenediamine | 6.30e-05 | 3 | 105 | 2 | CID000067105 | |
| Drug | N(3)ATP | 6.30e-05 | 3 | 105 | 2 | CID000133414 | |
| Drug | acetyl-dephospho-CoA | 6.30e-05 | 3 | 105 | 2 | CID000193680 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.11e-06 | 195 | 104 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 1.23e-05 | 2 | 104 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | otitis media (biomarker_via_orthology) | 2.79e-05 | 17 | 104 | 3 | DOID:10754 (biomarker_via_orthology) | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 1.22e-04 | 5 | 104 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | Retinitis pigmentosa | 1.39e-04 | 74 | 104 | 4 | cv:C0035334 | |
| Disease | fatty liver disease (implicated_via_orthology) | 1.78e-04 | 31 | 104 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 1.83e-04 | 6 | 104 | 2 | C1854678 | |
| Disease | asthma (is_implicated_in) | 2.41e-04 | 157 | 104 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | Vasogenic Brain Edema | 3.40e-04 | 8 | 104 | 2 | C0750969 | |
| Disease | Cytotoxic Brain Edema | 3.40e-04 | 8 | 104 | 2 | C0750970 | |
| Disease | Cytotoxic Cerebral Edema | 3.40e-04 | 8 | 104 | 2 | C0472388 | |
| Disease | Vasogenic Cerebral Edema | 3.40e-04 | 8 | 104 | 2 | C0472387 | |
| Disease | Brain Edema | 3.40e-04 | 8 | 104 | 2 | C1527311 | |
| Disease | Cerebral Edema | 3.40e-04 | 8 | 104 | 2 | C0006114 | |
| Disease | Adenoid Cystic Carcinoma | 4.40e-04 | 100 | 104 | 4 | C0010606 | |
| Disease | Retinitis Pigmentosa | 5.11e-04 | 104 | 104 | 4 | C0035334 | |
| Disease | microphthalmia (implicated_via_orthology) | 7.94e-04 | 12 | 104 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 7.94e-04 | 12 | 104 | 2 | C0270960 | |
| Disease | Disorder of eye | 9.44e-04 | 212 | 104 | 5 | C0015397 | |
| Disease | 3-hydroxyphenylacetic acid measurement | 1.09e-03 | 14 | 104 | 2 | EFO_0010448 | |
| Disease | asthma (biomarker_via_orthology) | 1.20e-03 | 59 | 104 | 3 | DOID:2841 (biomarker_via_orthology) | |
| Disease | lifestyle measurement, anxiety disorder measurement | 1.43e-03 | 137 | 104 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.43e-03 | 16 | 104 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | nervousness | 1.43e-03 | 16 | 104 | 2 | NCIT_C74532 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.45e-03 | 63 | 104 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | Benign neoplasm of stomach | 1.62e-03 | 17 | 104 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.62e-03 | 17 | 104 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.62e-03 | 17 | 104 | 2 | C0154060 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.02e-03 | 19 | 104 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.02e-03 | 19 | 104 | 2 | C2936783 | |
| Disease | Mental Depression | 2.09e-03 | 254 | 104 | 5 | C0011570 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.20e-03 | 257 | 104 | 5 | DOID:10652 (is_marker_for) | |
| Disease | pentachlorophenol measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 2.30e-03 | 74 | 104 | 3 | EFO_0007886 | |
| Disease | Stomach Carcinoma | 2.47e-03 | 21 | 104 | 2 | C0699791 | |
| Disease | serum IgG glycosylation measurement | 2.56e-03 | 523 | 104 | 7 | EFO_0005193 | |
| Disease | epilepsy (implicated_via_orthology) | 2.69e-03 | 163 | 104 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | depressive disorder (implicated_via_orthology) | 2.71e-03 | 22 | 104 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | Acute Lung Injury | 2.71e-03 | 22 | 104 | 2 | C0242488 | |
| Disease | Hodgkins lymphoma | 3.08e-03 | 82 | 104 | 3 | EFO_0000183 | |
| Disease | apolipoprotein A 1 measurement | 3.10e-03 | 848 | 104 | 9 | EFO_0004614 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 3.23e-03 | 24 | 104 | 2 | DOID:1184 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WENTDWFKETKNQSV | 156 | O60637 | |
| WKNVRKNVDTYNPWD | 1191 | Q8WWZ7 | |
| WNVRYDEWIKADKIV | 611 | Q4LE39 | |
| LDYPNWNVAKQDDWV | 71 | Q8NHU2 | |
| QYRTWQKKLAEDSTW | 1156 | Q4VNC0 | |
| PYEQWSDQEIWKVAD | 1306 | P13569 | |
| FDQNLDTKWYQWKAT | 21 | O60911 | |
| QILKTSVWYQEVWND | 76 | O95264 | |
| TTNVWLKQEWSDYKL | 106 | Q15822 | |
| AYVWDNNKDLAEWLE | 2261 | Q13085 | |
| WIKFAQKRWIYEDVE | 96 | O43852 | |
| PQKTEEAVDQDKWYW | 476 | Q96CM8 | |
| VWDFVQSNWKKLFND | 876 | P15144 | |
| QNNEQAWKEILKWEA | 156 | P53701 | |
| YDERWKEKQEQGFTW | 691 | Q8IZT6 | |
| QELTKEWTNKWNETQ | 416 | Q96L93 | |
| EWTNKWNETQNILKE | 421 | Q96L93 | |
| EWQAKWSVESIFNKD | 121 | Q9HBI0 | |
| NAVQDWATQIKTYSW | 111 | P20337 | |
| WATQIKTYSWDNAQV | 116 | P20337 | |
| VQDWSTQIKTYSWDN | 121 | Q96E17 | |
| WATQIKTYSWDNAQV | 116 | O95716 | |
| KVDVLNQVDWNAWLY | 436 | P09960 | |
| YKIQKDKPETWENQW | 81 | Q15800 | |
| YQVEAWKTHVWQDEK | 491 | P35228 | |
| WDTDQWKTENYINES | 1541 | O60309 | |
| YSIEIWDSANKTWKE | 1366 | Q15746 | |
| VWKYNSSINKWIQIE | 391 | Q8WZ60 | |
| EEYQIQKWGNIEWAH | 241 | Q8N5M1 | |
| EWSKWELQPSVQYQE | 1836 | Q5T1H1 | |
| WDTDQWKIENYINES | 1541 | A6NM11 | |
| WDTDQWKIENYINES | 1541 | A6NMS7 | |
| NIYQDTTISWWKDGK | 121 | Q12866 | |
| HAWNINYKKWENEEE | 36 | Q96D96 | |
| AKWWKREIEELYNNP | 1391 | O43451 | |
| TAKWWKREIEELYNN | 2286 | O43451 | |
| DNSKWCADWYVEKVE | 1326 | Q8IVV2 | |
| LQSVKWYWKQEDKII | 931 | Q8IY21 | |
| WYWKQEDKIIENNTA | 936 | Q8IY21 | |
| EAKEKNRETWYLSWA | 241 | Q8IYD1 | |
| WVSELSYVEEKEQWQ | 986 | Q15154 | |
| KECWSWESYLEEQKA | 271 | Q9Y468 | |
| YWKVVNDKDKQQNSW | 526 | Q8N119 | |
| SEKQWKDNVNLAWSI | 1536 | P42356 | |
| TVFENWLYWIDKQQQ | 1151 | O75581 | |
| WTAYEKINKWTDNRE | 1016 | O60449 | |
| ELKDRQQIYCWATWK | 131 | P18054 | |
| SGKEENTDWSYEKQW | 66 | Q8N690 | |
| NYVHWNEDIGEWQLK | 606 | Q9Y496 | |
| PEHKKLYSWQQEAQW | 346 | Q8IVE3 | |
| TNKLCYEDDKLWSNW | 316 | P78552 | |
| QDFYWEAEWQELEKR | 491 | Q9UHB4 | |
| WQIFENPVDWKEKYI | 531 | O00469 | |
| DEYVKTRTLQNWKFW | 821 | Q9HAP2 | |
| HVTEYEDNLKNSWVW | 431 | Q16134 | |
| EDNLKNSWVWKELYS | 436 | Q16134 | |
| WQLEEAQVFWAKKEQ | 2291 | Q13315 | |
| EAAWKLSQWDLVENY | 1776 | Q13535 | |
| YWRNEFDWKKQVEIL | 96 | P07099 | |
| EDKNRDEQLKYWKYW | 306 | Q6ISB3 | |
| NKPENWDVWYESKFD | 321 | Q8NDZ4 | |
| RKKEWWENAGNKIYT | 2001 | Q5TH69 | |
| FEEFKYLWNNIKKWQ | 141 | Q96L46 | |
| NVKKTDWFQEWPDSY | 26 | Q9NP62 | |
| AQDWALAKKYDQWTI | 56 | Q5T5S1 | |
| AWKIWNVIYEENCFK | 196 | Q96HE7 | |
| VSFFAKWWDNINVQK | 216 | P49641 | |
| WEEIKSAKYSEAWQS | 151 | Q8NA03 | |
| EHLKEEWNKSDQYWL | 221 | O00237 | |
| YTHEKWAFDKIQNNW | 2761 | P21817 | |
| AAWKFIKDNWEELYN | 826 | P55786 | |
| YEKYNKWETIEAWTQ | 116 | P15086 | |
| NWKQYKQEDSIWTFA | 116 | Q8WYK1 | |
| KLEWSQKCLQDNEWN | 586 | Q9GZY0 | |
| SVYHIKWIQWKEENT | 241 | Q8NBR6 | |
| DLETWDWDNKQNKQL | 736 | Q9HCH5 | |
| INVWTKEYEGNVTWK | 151 | P0DTE0 | |
| RKKENSLDWEDWQYF | 401 | O75445 | |
| FQRASAKWKDDVQLW | 96 | Q9NYH9 | |
| AKWKDDVQLWLSYVA | 101 | Q9NYH9 | |
| NMLQWEELEWQKYAE | 721 | Q9NRR4 | |
| EWNCNKEKWLYALED | 256 | Q2M3C7 | |
| IAVFKNEIYWDDWSQ | 966 | Q92673 | |
| VYKSEIKWWLDGNKN | 1126 | Q8IVG5 | |
| DKVWQKDEEYTWVLN | 581 | Q7Z443 | |
| DQLTKDWTQKWNDWQ | 441 | Q9P2P6 | |
| WAYQQVQQNKEDAWI | 176 | Q6NZ63 | |
| YTRKNVCWLNWEDTK | 1156 | Q8IZF2 | |
| DNNKYWLVKNSWGEE | 291 | P07711 | |
| NTEKEKQLKAWEWRY | 241 | Q8N957 | |
| RQEKTANWVSEYWLN | 186 | P28329 | |
| IKWFDYLWTNKKTVD | 431 | P29973 | |
| KWDEPWYNQKTEHQR | 316 | Q9Y2G3 | |
| AAYENSKWEPVKWEN | 951 | Q9BXT8 | |
| KTIEWYRENFHNWKN | 326 | O95455 | |
| KWEDQSIEDWYKNQG | 46 | Q8TBZ8 | |
| YELDWDEPQWKEKQS | 101 | Q7Z392 | |
| IVWDEKKNQWVNLNE | 2131 | O15027 | |
| QKVKVWLQEYWNVTD | 956 | Q9HCF6 | |
| LLNSTNKDWWKVEVN | 996 | Q13813 | |
| DNTTKYNSEWWVLNL | 2621 | Q9H5I5 | |
| DNSKYWVLWKDIQHA | 76 | Q5T6S3 | |
| FDKQEQNAEDWNLYW | 111 | Q9BWV7 | |
| HKDQLQEYEKQWKTW | 471 | P49750 | |
| SWIQEINVAEKNWYP | 4026 | P78527 | |
| QEWQDLEAWQKELYK | 21 | Q8N393 | |
| WYQQWKDFKENNVVF | 241 | O43615 | |
| WIWTSYIINQAKKEN | 1131 | Q12789 | |
| EENDSNIWKFWYTNQ | 66 | Q6ZP80 | |
| YFSEDEWKNLDEWQK | 206 | Q9UDV7 | |
| EWKNLDEWQKELYNN | 211 | Q9UDV7 | |
| WTDWQTKSIQRVDKY | 1571 | O75096 | |
| QNEREYRLDWAKWKA | 4041 | P20929 |